Clinical Roundup UCLA study: Combination of breast cancer and chemo may speed physical decline in older adults May 17, 2024Vol.50 No.20
Clinical Roundup Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival May 17, 2024Vol.50 No.20
Clinical Roundup Soligenix reports positive clinical results from synthetic hypericin compatibility study for CTCL May 17, 2024Vol.50 No.20
Clinical Roundup Alligator Bioscience initiates phase I study of intratumoral mitazalimab in locally advanced pancreatic cancer May 17, 2024Vol.50 No.20
Clinical Roundup Kyowa Kirin forms global collaborative with advocacy groups to address unmet needs in cutaneous T-cell lymphoma May 17, 2024Vol.50 No.20
Clinical Roundup Merck discontinues arm of phase III trial evaluating vibostolimab + pembrolizumab in adjuvant high-risk melanoma May 17, 2024Vol.50 No.20
Drugs & Targets FDA, EMA grant Orphan Drug Designation to Carthera for carboplatin with SonoCloud technology in glioma May 17, 2024Vol.50 No.20
Drugs & Targets Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation May 17, 2024Vol.50 No.20
Trials & Tribulations Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity May 10, 2024Vol.50 No.19By Sanju Sinha and Eytan Ruppin
